findinEsegui ricerca

SR One

Organisation available for the Professional Exchange Call: 2 (Aug 2013 - Oct 2013)

Type of organisation: Venture Capital Firm


Recommended stay period: 4-6 weeks

SR One

Areas of expertise looked for:
Spin-offs creation, Investment analysis

SR One is the corporate venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.

We have a team of investment professionals, located in the US and UK. As a Team, our experience spans basic science, industry and the market. We take an active role in our portfolio companies and work with management teams and our fellow venture investors to create significant value.

Our current portfolio includes approximately 30 private and public companies and since our founding in 1985, we have invested over $680MM in the biotech space.

Our expanded remit also focuses on maximizing the value of GSK technological innovation to establish new businesses and revenue opportunities across a range of industries.

Contact Point
Name: Mark Wilson
Function: Director, SR One
Address :Park Road, Ware, Hertfordshire, SG12 0DP, United Kingdom
Phone: +44-7879-694788

This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA